Evidence map›Paper›PMID 23101717›Full record

ArticleLancet (London, England)2012

Systems biology and cardiac arrhythmias.

Andrew A Grace, Dan M Roden

Abstract read
In one paragraph

Article in Lancet (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Long-term spaceflight and the cardiovascular system.Precision clinical medicine · 2020
    Article
  9. Article
  10. Review
  11. Effective Patient Care in a Data-Driven World.Arrhythmia & electrophysiology review · 2017
    Article
  12. Review
  13. Article
  14. Review
  15. Clinical Electrophysiology and Precision Medicine Initiatives.Arrhythmia & electrophysiology review · 2015
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Andrew A GraceDepartment of Biochemistry, University of Cambridge, Cambridge, UK. aag1000@cam.ac.uk
Dan M Roden

Funding

PHARMACOGENOMICS OF ARRHYTHMIA THERAPYU01HL065962 · NHLBI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2001 to 2009
$24.8M
Pharmacogenomics of Arrhythmia TherapyU19HL065962 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2010 to 2014
$17.4M
MODULATION OF CARDIAC REPOLARIZATIONR01HL049989 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 1994 to 2015
$5.2M
Biotechnology and Biological Sciences Research CouncilBritish Heart FoundationMedical Research CouncilNHLBI NIH HHS HL49989NHLBI NIH HHS HL65962NHLBI NIH HHS R01 HL049989NHLBI NIH HHS U01 HL065962NHLBI NIH HHS U19 HL065962Wellcome Trust
6 · The paper itself

Abstract

During the past few years, the development of effective, empirical technologies for treatment of cardiac arrhythmias has exceeded the pace at which detailed knowledge of the underlying biology has accumulated. As a result, although some clinical arrhythmias can be cured with techniques such as catheter ablation, drug treatment and prediction of the risk of sudden death remain fairly primitive. The identification of key candidate genes for monogenic arrhythmia syndromes shows that to bring basic biology to the clinic is a powerful approach. Increasingly sophisticated experimental models and methods of measurement, including stem cell-based models of human cardiac arrhythmias, are being deployed to study how perturbations in several biologic pathways can result in an arrhythmia-prone heart. The biology of arrhythmia is largely quantifiable, which allows for systematic analysis that could transform treatment strategies that are often still empirical into management based on molecular evidence.

Indexed as

Systems BiologyAnimalsArrhythmias, CardiacAtrial FibrillationComputational BiologyDeath, Sudden, CardiacElectrocardiographyFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHeart Conduction SystemHumansIncidenceLong QT SyndromeMalePhenotype

Identifiers

PMID23101717
PMCPMC3745651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.